These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6195613)

  • 1. The use of amiodarone in children.
    Coumel P; Lucet V; Do Ngoc D
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):930-9. PubMed ID: 6195613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and pharmacology of amiodarone.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
    Coumel P; Fidelle J
    Am Heart J; 1980 Dec; 100(6 Pt 2):1063-9. PubMed ID: 7446409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The place of amiodarone in 1979 in the therapeutic arsenal of a cardiac intensive care unit].
    Demoulin JC; Legrand V
    Rev Med Liege; 1979 Dec; 34(23):963-8. PubMed ID: 550265
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
    Graboys TB; Podrid PJ; Lown B
    Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing.
    Singh BN; Nademanee K; Kannan R; Ikeda N
    Pacing Clin Electrophysiol; 1984 Jan; 7(1):109-24. PubMed ID: 6199755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
    Best JF; Rinkenberger R; Lynch L; Dunn M
    Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart.
    Shenasa M; Denker S; Mahmud R; Lehmann M; Estrada A; Akhtar M
    J Am Coll Cardiol; 1984 Jul; 4(1):105-10. PubMed ID: 6736436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
    Peter T; Hamer A; Mandel WJ
    Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias.
    Finerman WB; Hamer A; Peter T; Weiss D; Mandel WJ
    Am Heart J; 1982 Nov; 104(5 Pt 1):987-96. PubMed ID: 7137016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K; Singh BN; Hendrickson JA; Reed AW; Melmed S; Hershman J
    Circulation; 1982 Jul; 66(1):202-11. PubMed ID: 7083508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.